
南美洲和中美洲临床试验用品市场预测至 2027 年 - 按产品和服务(制造、包装和标签以及物流和分销)、阶段(第一阶段、第二阶段、第三阶段和生物等效性研究)划分的 COVID-19 影响和区域分析)、药物类型(小分子药物和生物药物)和应用(肿瘤、心血管疾病、神经系统疾病、呼吸系统疾病等)
No. of Pages: 122 | Report Code: TIPRE00022068 | Category: Life Sciences
No. of Pages: 122 | Report Code: TIPRE00022068 | Category: Life Sciences
临床试验是一项调查研究,定义医疗方法、疗法或设备是否有效,安全且对人类应用有用。这些研究有助于找到最适合某些疾病的治疗方法实验。临床试验用品管理对于避免生产过剩、供应过剩和库存过期是必要的。随着药物发现成本的不断增加,临床试验用品变得越来越重要。
南美洲和中美洲临床试验用品市场预计将从2019年的9961万美元增至2027年的1.6429亿美元;预计2020年至2027年复合年增长率为6.5%。市场的增长归因于一些关键驱动因素,例如制药和制药行业研发支出的增加。生物制药公司、临床试验数量的增加以及发达国家药物开发成本的增加。然而,由于 COVID-19 大流行的负面影响,临床试验面临的挑战预计将在预测几年内抑制市场的增长。
临床试验是一项研究性试验定义医疗方法、疗法或设备是否有效、安全且对人类应用有用的研究。这些研究有助于找到最适合某些疾病的治疗方法。临床试验用品管理对于避免生产过剩、供应过剩和库存过期是必要的。随着药物发现成本的不断增加,临床试验用品变得越来越重要。研究与开发 (R&D) 是制药和生物制药公司业务的重要组成部分。多年来,生物制药公司的研发支出不断增加。根据美国药物研究与制造商协会(PhRMA)的报告,这些公司的研发支出从2015年的596亿美元增加到2018年的796亿美元。药物开发和发现是一个耗时且耗时的过程。昂贵的过程。流程阶段从早期检测或设计到开发和监管审批,整个过程可能需要 10-15 年以上。在整个药物开发阶段,需要各种测试服务来检查原料药的质量和功效。多家制造商正在投资制药行业的临床用品。因此,制药和生物技术公司依赖于临床试验服务的供应,预计这将推动市场。此外,先进的医疗保健基础设施以及在南美洲和中美洲开展临床试验的跨国制药和生物技术公司的存在将促进市场增长。
自新冠疫情激增以来-19情况下,医药行业面临产能下降,导致药品短缺。此外,将资源从药物开发转移到冠状病毒治疗可能会在短期内阻碍药物开发的整体生产力。由于供应链中断和病毒威胁,多家制药公司决定推迟正在进行的临床试验。然而,由于南美洲和中美洲商业部门的经济损失,这些程序和做法现已重新启动。因此,COVID-19 大流行对南美洲和中美洲临床试验用品市场产生了积极和消极的影响。
基于产品和技术服务,南美洲和中美洲临床试验用品市场分为制造、包装和服务。标签、物流和分配。物流及2019年,分销领域占据最大市场份额;预计同一细分市场在预测期内的复合年增长率最高。
就阶段而言,南美洲和中美洲临床试验用品市场分为几个阶段I、II 期、III 期和生物等效性研究。 III 期细分市场在 2019 年占据了最大的市场份额,预计在预测期内的市场复合年增长率最高。
根据药物类型,南方市场中美洲临床试验用品市场分为小分子药物和生物药物。小分子药物领域在 2019 年占据了最大的市场份额,而生物药物领域预计在预测期内的市场复合年增长率最高。
在应用方面,南美洲和中美洲临床试验用品市场已细分为肿瘤、心血管疾病、神经系统疾病、呼吸系统疾病等。肿瘤学领域在 2019 年占据了最大的市场份额,预计在预测期内复合年增长率最高。
< p>
与本报告相关的一些主要和次要来源南美洲和中美洲临床试验用品市场的监管机构包括卫生和预防部 (MoHAP)、美国药物研究和制造商 (PhRMA) 以及临床研究组织协会(ACRO)。
按产品和技术分类服务
按阶段
按药物类型
按应用
Strategic insights for South and Central America Clinical Trials Supplies involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 99.61 Million |
Market Size by 2027 | US$ 164.29 Million |
Global CAGR (2020 - 2027) | 6.5% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By 产品与服务
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South and Central America Clinical Trials Supplies refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Clinical Trials Supplies Market is valued at US$ 99.61 Million in 2019, it is projected to reach US$ 164.29 Million by 2027.
As per our report South and Central America Clinical Trials Supplies Market, the market size is valued at US$ 99.61 Million in 2019, projecting it to reach US$ 164.29 Million by 2027. This translates to a CAGR of approximately 6.5% during the forecast period.
The South and Central America Clinical Trials Supplies Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Clinical Trials Supplies Market report:
The South and Central America Clinical Trials Supplies Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Clinical Trials Supplies Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Clinical Trials Supplies Market value chain can benefit from the information contained in a comprehensive market report.